Skip to content
Explore the latest in technology, innovation, and digital c…

Zimbabwe Turns Down ‘Unbalanced’ American Health Aid Agreement Because of Data Concerns

Health funding illustration
The offered US funding was aimed at initiatives for HIV/Aids treatment and prevention, tuberculosis, and malaria.

Zimbabwe has rejected a substantial US healthcare agreement valued at 367 million US dollars (272 million pounds) over five years because of the United States' insistence on sensitive information.

This rejection became public after a internal memorandum from December was leaked, which showed Head of State Emmerson Mnangagwa deemed the arrangement was "skewed".

A government spokesperson later stated that the United States was demanding access to biological samples for scientific study and commercial gain but was not willing to share the benefits from any future treatments.

"We must now begin the difficult and regrettable process of ending our health assistance in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont publicly.

The US Embassy indicated the United States had provided more than $1.9bn in health funding to Zimbabwe during the past twenty years.

A doctors' association in Zimbabwe has urged continued negotiations to reach a agreement acceptable to all parties so the nation's critical HIV treatment initiative can proceed.

Wider Context

Zimbabwe's decision follows a comparable case in Kenya, where a court suspended a related health funding agreement following legal challenges were filed about the security of Kenyans' health data.

Since returning to office recently, US President Donald Trump has reduced overseas assistance and shut down the US Agency for International Development (USAID).

USAID had overseen assistance for the American government, but Trump claimed its expenditure was "inefficient" and his administration was seeking government-to-government agreements to enhance openness and responsibility.

Based on statements, 16 nations in Africa have to date signed similar agreements, representing more than $18.3bn of fresh investment.

Details of the Rejected Agreement

The money for Zimbabwe was intended to funded "HIV/Aids treatment and prevention, tuberculosis, malaria, maternal and child health, and preparing for epidemics".

"It is our view this cooperation could have provided significant benefits for the people of Zimbabwe, especially the 1.2 million currently receiving HIV treatment via US-supported initiatives," Tremont commented.

However, official spokesman Nick Mangwana said the proposed deal was "unfair".

"Zimbabwe was being asked to share its genetic material and health information indefinitely, without any equivalent promise of access to any medical innovations – like vaccines, diagnostics, or treatments – that might result from that provided information," he stated.

"In essence, our country would provide the basic resources for medical research with no assurance that the final treatments would be available to our citizens if a new disease outbreak emerge."

Sovereignty and International Frameworks

Mangwana further pointed out that the American exit from the World Health Organization (WHO) and its push of one-on-one health agreements were disrupting frameworks previously set up via the international organization.

The spokesperson gave as an example its Pandemic Benefit-Sharing framework designed to manage future global health emergencies.

"This framework is designed to ensure that when a nation provides its samples, the resulting advantages – including vaccines and treatments – are distributed fairly, not monopolised exclusively by those with the resources to create them."

Zimbabwe's reservations over the US deal "are not meant as anti-American sentiment," Mangwana stressed.

"We are open to further dialogue with our US partners on how subsequent co-operation could be designed in a manner that respects the sovereignty and dignity of both nations."

Health Experts Response

A leading public health body stated it recognised the government's concerns, but suggested that talks need to persist since much of the nation's Aids initiatives depended on foreign aid.

"If technical issues arise, including those relating to information security or implementation frameworks, these can frequently be addressed via detailed discussion and negotiated safeguards," the group said.

The halted deal highlights the continuing tensions between receiving vital international aid and safeguarding national sovereignty in an ever more interconnected world.

About the author

Philip Evans

A tech enthusiast and writer based in Amsterdam, covering emerging technologies and their impact on society.

OpenTalkZone

Type to search articles.